Published Work
Journals:
Pilot clinical and pharmacokinetic study of Δ 9 - Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain https://pubmed.ncbi.nlm.nih.gov/36240167/
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions https://pubmed.ncbi.nlm.nih.gov/35796920/
Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829707/
Enhancing Endocannabinoid Control of Stress with Cannabidiol https://www.mdpi.com/2077-0383/10/24/5852/htm
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations https://pubmed.ncbi.nlm.nih.gov/34777578/
A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study https://pubmed.ncbi.nlm.nih.gov/34357480/ R E V I E W
Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19 https://pubmed.ncbi.nlm.nih.gov/34546607/
Butyrate Sensitizes Epithelioid Mesothelioma Cells to Oxaliplatin https://www.researchgate.net/publication/351933122_Butyrate_Sensitizes_Epithelioid_Mesothelioma_Cells_to_Oxaliplatin
Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19 https://onlinelibrary.wiley.com/doi/10.1002/rmv.2211
An oro-buccal nanoparticle delivered cannabis medicine for pain management in cancer: A clinical trial in progress. https://ascopubs.org/doi/10.1200/JCO.2020.38.15_suppl.TPS12127
A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes https://www.mdpi.com/2305-6320/7/4/22
Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189397/
The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa https://www.mdpi.com/2079-4983/9/4/73
The Plasma Bioavailability of Coenzyme Q10 Absorbed from the Gut and the Oral Mucosa https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306788/
The Brain-Intestinal Mucosa-Appendix-Microbiome-Brain Loop https://www.ncbi.nlm.nih.gov/pubmed/29614774
Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum http://www.mdpi.com/2079-4983/9/1/12/html
Adjuvant Probiotics and the Intestinal Microbiome: Enhancing vaccines and immunotherapy outcomes http://www.mdpi.com/2076-393X/5/4/50
Probiotics, D-Lactic acidosis, oxidative stress and strain specificity https://www.ncbi.nlm.nih.gov/pubmed/28080206
Perna canaliculus and the Intestinal Microbiome https://www.ncbi.nlm.nih.gov/pubmed/28665349
A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested https://www.ncbi.nlm.nih.gov/pubmed/28155119
Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. https://www.ncbi.nlm.nih.gov/pubmed/27854317
Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences http://www.mdpi.com/2076-2607/3/4/913
Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology https://pubmed.ncbi.nlm.nih.gov/26462363/
Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity http://journal.frontiersin.org/Journal/10.3389/fcimb.2014.00143/abstract
The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures http://www.ncbi.nlm.nih.gov/pubmed/25244509
Probiotics, prebiotics and the gastrointestinal tract in health and disease http://link.springer.com/article/10.1007%2Fs10787-014-0201-4